Finance

Lists
Why is NAUT up 24,84%?
Dive Deeper
NAUT:NASDAQ
Nautilus Biotechnology Inc
1,96 $
+24,84%
(+0,39) 1D
2,20 $
+12,24% (+0,24)
After hours
Closed: 2 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NAUT...
Open
1,65 $
High
1,97 $
Low
1,60 $
Mkt. cap
249,42 մլն
Avg. vol.
2,41 մլն
Volume
13,02 մլն
52-wk high
4,31 $
52-wk low
0,82 $
EPS
-0,45 $
Beta
0,73
Shares outstanding
127,26 մլն
No. of employees
127
Open
1,65 $
High
1,97 $
Low
1,60 $
Mkt. cap
249,42 մլն
Avg. vol.
2,41 մլն
Volume
13,02 մլն
52-wk high
4,31 $
52-wk low
0,82 $
EPS
-0,45 $
Beta
0,73
Shares outstanding
127,26 մլն
No. of employees
127
News stories
From web sources and news partners
About Nautilus Biotechnology Inc
CEO-
Employees127
Founded2016
HeadquartersՍիեթլ, Վաշինգտոն, Միացյալ Նահանգներ
Sector-
Websitenautilus.bio
Analyst ratings
Based on 3 analysts giving stock ratings to NAUT in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NAUT in the last 3 months.
Highest
Current 1,96 $
4,00 $ (+104,08%)
Average
3,83 $ (+95,41%)
Lowest
3,50 $ (+78,57%)
Analyst
Recommendation
Action
Price target
Projected
Date
Max Masucci
Roth MKM
Buy
Initiated
3,50 $
+78,6%
09/29/2026
Unknown Analyst
Leerink Partners
Buy
Initiated
4,00 $
+104,1%
09/09/2026
Subbu Nambi
Guggenheim
Buy
Reiterated
4,00 $
+104,1%
07/28/2026
Daniel Brennan
TD Cowen
Buy
Maintained
-
-
04/28/2026
Last report
28 հլս, 2026 թ.
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,11 $ / -0,14 $
+21,43%beat
Revenue / Est. (USD)
190,00 հզր / 0,00
0,00%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
190,00 հզր
Cost of goods sold
-
-
-
15,00 հզր
Cost of revenue
-
-
-
15,00 հզր
Research and development expenses
9,60 մլն
9,58 մլն
9,71 մլն
9,61 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,87 մլն
5,85 մլն
6,42 մլն
6,32 մլն
Operating expense
15,47 մլն
15,42 մլն
16,12 մլն
15,94 մլն
Total operating expenses
15,47 մլն
15,42 մլն
16,12 մլն
15,95 մլն
Operating income
-15,47 մլն
-15,42 մլն
-16,12 մլն
-15,76 մլն
Other non operating income
-5,00 հզր
-145,00 հզր
-15,00 հզր
-13,00 հզր
EBT including unusual items
-13,57 մլն
-13,78 մլն
-14,70 մլն
-14,47 մլն
EBT excluding unusual items
-13,57 մլն
-13,92 մլն
-14,70 մլն
-14,47 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-13,57 մլն
-13,78 մլն
-14,70 մլն
-14,47 մլն
Net profit margin
-
-
-
-7 615,26%
Earnings per share
-
-
-
-
Interest and investment income
1,90 մլն
1,65 մլն
1,44 մլն
1,31 մլն
Interest expense
-
-
-
-
Net interest expenses
1,90 մլն
1,65 մլն
1,44 մլն
1,31 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-15,05 մլն
-15,02 մլն
-15,79 մլն
-15,49 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps